-
Helpful Apps for People Living with Cancer
As mobile apps become more ingrained in our lives, it’s natural to look for ones that can help manage a cancer diagnosis. As for which app to choose, it really comes down to what you’re looking for...
IN THE SPOTLIGHT
-
Clinical Trial Phases
The four phases of lung cancer clinical trials each serve a different and important purpose. From testing the safety of a new treatment to its effectiveness and long-term outcomes... -
LUNGevity Announces $1.2M in Lung Cancer Workforce Development Research Awards
LUNGevity Foundation is proud to announce the recipients of four awards to bolster the lung cancer research workforce— the Career Development Award, the VA Research Scholar Award... -
Treatment & Research Takeaways: ESMO 2023 Meeting
The European Society for Medical Oncology (ESMO) recently held its annual conference from October 20 – 24, 2023 in Madrid, Spain. ESMO represents one of the largest gatherings of... -
Be Part of the Largest Lung Cancer Event in the Nation
November is Lung Cancer Awareness Month, when the lung cancer community gathers to raise awareness for this disease and stand together – unified and strong. You can get involved in... -
ALK Virtual Meetup
ALK patients/survivors - Join us the 4th Wednesday of every month to connect with others who share common experiences and build your community. -
What Is a Clinical Trial
Lung cancer clinical trials are carefully designed research studies to evaluate and learn more about new drugs and treatments. They give people the ability to participate in lung... -
Watch Recorded Expert Sessions From ILCSC
The International Lung Cancer Survivorship Conference (ILCSC) is a free virtual educational conference for people with lung cancer, caregivers, and advocates. The 2023 conference... -
Transportation to Treatment
At some point, transportation to appointments becomes a challenge for everyone. Whether it be the cost, time commitment, or finding reliable transportation, we share some tips for...
Clinical Trial Phases
Clinical Trial Phases
The four phases of lung cancer clinical trials each serve a different and important purpose. From testing the safety of a new treatment to its effectiveness and long-term outcomes, this short video explains how researchers use clinical trials for new lung cancer treatments.Phases of a Clinical Trial:1. Safety of the new treatment 2. Does the cancer respond to the treatment 3. Is this new treatment better than the current options 4. Studies the long-term benefits and side effects
Helpful Apps for People Living with Cancer
Helpful Apps for People Living with Cancer
As mobile apps become more ingrained in our lives, it’s natural to look for ones that can help manage a cancer diagnosis. As for which app to choose, it really comes down to what you’re looking for, what you’re comfortable with, and what fits your needs. This list of helpful apps for people living with cancer includes ones that range from very basic, essentially a mobile pen and piece of paper, to all-in-one solutions that make medication tracking, document management, and communication easier…
LUNGevity Announces $1.2M in Lung Cancer Workforce Development Research Awards
LUNGevity Announces $1.2M in Lung Cancer Workforce Development Research Awards
LUNGevity Foundation is proud to announce the recipients of four awards to bolster the lung cancer research workforce— the Career Development Award, the VA Research Scholar Award, the Health Equity and Inclusiveness Research Fellow Award, and the ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant.“Progress in lung cancer research is only possible with a vibrant and diverse thoracic oncology workforce,” notes Upal Basu Roy, PhD, MPH, executive director, LUNGevity Research. “We…
Finding (Mental) Peace this Holiday Season
Finding (Mental) Peace this Holiday Season
The holidays are stressful enough without having to deal with lung cancer. LUNGevity is here to help.This discussion of the mental health challenges we face in the lung cancer community includes strategies for coping with a lung cancer diagnosis, stigma, and holiday anxiety. With the daylight getting shorter, we also discuss tips to address seasonal affective disorder. The free support programs and services available through LUNGevity for patients and caregivers are highlighted.This webinar…
Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations
Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations
Treatment & Research Takeaways: ESMO 2023 Meeting
Treatment & Research Takeaways: ESMO 2023 Meeting
The European Society for Medical Oncology (ESMO) recently held its annual conference from October 20 – 24, 2023 in Madrid, Spain. ESMO represents one of the largest gatherings of the international oncology community, and this year’s meeting had over 30,000 registered attendees from around the world. Though October 19th brought record rainfall to Madrid, breaking a 100-year record, the rain in Spain didn’t dampen the palpable excitement of this year’s meeting. This was an especially exciting…
Innovative Therapeutic Vaccine for ALK+ NSCLC Heads to Phase 1 Clinical Trial
Innovative Therapeutic Vaccine for ALK+ NSCLC Heads to Phase 1 Clinical Trial
Different types of lung cancer are known to be caused, or driven, by alterations in genes such as EGFR or ALK. One such alteration, the fusion of the ALK gene with another gene (usually EML4), occurs in approximately 5% of patients with non-small cell lung cancer (NSCLC). Over the past several years, tyrosine kinase inhibitors (TKIs) have been approved to treat advanced ALK-positive lung cancers and may have fewer side effects with improved quality of life for patients. However, as with most…
What Is a Clinical Trial
What Is a Clinical Trial
Lung cancer clinical trials are carefully designed research studies to evaluate and learn more about new drugs and treatments. They give people the ability to participate in lung cancer research and access to new treatments that otherwise may not be available to them, all under the close supervision of medical experts.
Watch Recorded Expert Sessions From ILCSC
Watch Recorded Expert Sessions From ILCSC
The International Lung Cancer Survivorship Conference (ILCSC) is a free virtual educational conference for people with lung cancer, caregivers, and advocates. The 2023 conference was held September 22-23. The recorded sessions from this conference are available to registered participants through December 21, 2023, at www.lungevity.org/ilcsc. If you did not register for the conference but would like to view the recordings, you may still register for free access. The recordings are available…
The Latest Lung Cancer Science: Highlights of WCLC 2023
The Latest Lung Cancer Science: Highlights of WCLC 2023
I had the privilege of attending the 2023 World Conference on Lung Cancer (WCLC) in Singapore with my colleague Dr. Bellinda King-Kallimanis. WCLC, the world's largest meeting dedicated to lung cancer and other thoracic malignancies, is an excellent forum for learning about the latest research into the early detection and treatment of lung cancer. Apart from the science, it was inspiring to see fellow advocates and network with brilliant researchers, all razor-focused on improving the outcomes…
Lung Cancer and NCCN Guidelines: What They Are and Why They Matter
Lung Cancer and NCCN Guidelines: What They Are and Why They Matter
In this expert meetup session, Carlin Callaway will review the National Comprehensive Cancer Network’s (NCCN’s) Non-Small Cell Lung Cancer (NSCLC) Guidelines and discuss how they are applicable to patient care. Participants will be able to ask general questions and engage in meaningful conversation.An expert in the field, Carlin Callaway, DNP, RN, ACNP-BC, ACNS-BC, AOCNP is Assistant Professor and the Lead Medical Oncology Advanced Practice Provider at the University of Colorado Cancer Center…
Be Part of the Largest Lung Cancer Event in the Nation
Be Part of the Largest Lung Cancer Event in the Nation
November is Lung Cancer Awareness Month, when the lung cancer community gathers to raise awareness for this disease and stand together – unified and strong. You can get involved in raising awareness about lung cancer by joining LUNGevity on Saturday, November 4, 2023, for our nationwide walk, Breathe Deep TOGETHER. Thousands of people from across the country, coming together in a singular event, is a powerful way to make our voices heard and increase the visibility of lung cancer.Together, we…
Transportation to Treatment
Transportation to Treatment
At some point, transportation to appointments becomes a challenge for everyone. Whether it be the cost, time commitment, or finding reliable transportation, we share some tips for overcoming or avoiding these issues when they arise.
ICYMI: Alecensa Exhibited Unprecedented Results for Patients with Early-Stage Lung Cancer
ICYMI: Alecensa Exhibited Unprecedented Results for Patients with Early-Stage Lung Cancer
Alectinib shows promise in early-stage ALK-positive non-small cell lung cancer
Brigatinib Not Superior to Alectinib in ALK-Positive NSCLC
Phase 3 Trial Results Show Adjuvant Alectinib Reduces Recurrence, Mortality in Early-Stage ALK-Positive NSCLC
Phase 3 Trial Results Show Adjuvant Alectinib Reduces Recurrence, Mortality in Early-Stage ALK-Positive NSCLC
Lung cancer biomarker campaign, launched with AstraZeneca, boosts its reach and adds pharma supporters
Lung cancer biomarker campaign, launched with AstraZeneca, boosts its reach and adds pharma supporters
Alectinib Meets DFS End Point in ALK+ Early-Stage NSCLC
Trial-first for Roche lung cancer ALK inhibitor
Following in Tecentriq's footsteps, Alecensa gives Roche another win in early-stage lung cancer
Following in Tecentriq's footsteps, Alecensa gives Roche another win in early-stage lung cancer
Genentech's Alecensa shows promise in Phase III study for early-stage ALK-positive lung cancer
Genentech's Alecensa shows promise in Phase III study for early-stage ALK-positive lung cancer
Roche claims study success for targeted drug in early lung cancer
Decentralized Trials: Bringing Clinical Trials Closer to the Patient
Decentralized Trials: Bringing Clinical Trials Closer to the Patient
While participating in clinical trials can provide substantial benefits to people with lung cancer, the resources required to do so may pose significant hurdles, especially to those who don’t live close to where trials are held, such as academic medical centers or major oncology network sites. Decentralized clinical trials remove some hurdles to trial participation for patients and are thus important for improving trial access for larger and more diverse groups of people. The U.S. Food and Drug…
LUNGevity's International Lung Cancer Survivorship Conference
LUNGevity's International Lung Cancer Survivorship Conference
LUNGevity's 2023 International Lung Cancer Survivorship Conference features something for everyone! Our lineup of internationally renowned lung cancer experts will be covering a diverse range of topics, including how air pollution may contribute to lung cancer development, advances in early-stage treatment, the role of integrative medicine and complementary medicine approaches in disease management, addressing brain metastases, and tackling the challenge of histological transformation from…
A Look at NSCLC and Its Current and Emerging Therapies
2023 ASCO: Highlights of Lung Cancer Research
2023 ASCO: Highlights of Lung Cancer Research
Recently, members of LUNGevity Foundation joined thousands of attendees from the US and around the world, including oncologists, scientists, biotech and pharmaceutical representatives, advocates, and patients, to discuss lifesaving cancer research at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago from June 2 through June 6, 2023. The theme for this year’s conference, “Partnering With Patients: The Cornerstone of Cancer Care and Research,” was in recognition of…
Advocate Spotlight: Sydney Barned
Advocate Spotlight: Sydney Barned
Meet Dr. Sydney Barned, a lung cancer survivor-advocate from Jamaica who currently lives in Maryland.Sydney draws upon her unique experience as a physician and as a person living with lung cancer to help empower lung cancer patients and caregivers and to educate fellow healthcare providers and the public about the realities of lung cancer. Sydney is a doctor of internal medicine and a hospitalist. She was 33 years old and beginning her medical residency when she was unexpectedly diagnosed with…
dr Liu on the importance of NGS testing in NSCLC
Navigating Hope: How Comprehensive Biomarker Testing is Guiding Lung Cancer Care
Navigating Hope: How Comprehensive Biomarker Testing is Guiding Lung Cancer Care
Join us for a discussion on lung cancer biomarkers to learn what biomarker testing is, why it’s important, and how it can be used to optimize your treatment plans. We are thrilled to welcome our panelists: Balazs Halmos, MD, a thoracic medical oncologist from Montefiore Medical Center in New York; Elizabeth Ravera, a patient navigator at Montefiore; and a patient living with lung cancer who tested positive for the ALK biomarker. The panel is moderated by LUNGevity's Amy Moore, PhD, VP of Global…